William N. Harwin MD
Breast Cancer, Gastrointestinal Cancer, Genitourinary Oncology
President, Founder, and Managing Partner of Florida Cancer Specialists www.flcancer.com
Join to View Full Profile
14270 Royal Harbour CtUnit 1021Fort Myers, FL 33908
Phone+1 239-485-2083
Dr. Harwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1983 - 1984- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1981 - 1983
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1979 - 1981
- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1978 - 1979
Baylor College of MedicineClass of 1978
Certifications & Licensure
FL State Medical License 1979 - 2025
UT State Medical License 2003 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Gulfshore Life Magazine: Top Doctors Castle Connolly, 2004-2014
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
- Top Doctors: Florida Castle Connolly, 2000
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsTITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancerDenise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky
Breast Cancer Research and Treatment. 2017-05-15 - 13 citationsBiosimilars: Opportunities to Promote Optimization Through Payer and Provider CollaborationChronis Manolis, K. K. Rajasenan, William Harwin, Scott McClelland, Maria Lopes
Journal of Managed Care & Specialty Pharmacy. 2016-08-31 - 12 citationsA phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia.Ian W. Flinn, Amy S. Ruppert, William N. Harwin, David M. Waterhouse, Steven W. Papish
American Journal of Hematology. 2016-07-22
Press Mentions
Hematology Oncology of Indiana, PC to Join the American Oncology Network, LLCApril 1st, 2019
American Oncology Network, LLC (AON) Introduces Specialty Oral Oncolytic PharmacyMarch 22nd, 2019- Florida Cancer Specialists Celebrates 35th AnniversaryMarch 13th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
